In our last post on vaporization, we looked at the rising rate of vaporization as an ingestion method among Tilray patients. Today, we look at the picture for Canada as a whole, and what this means for lawmakers nationwide.

Current trends suggest that the popularity of vaporization as a method of use for medical cannabis will continue to grow, and this has led to both positive and negative policy developments. On the one hand, more and more long and short-term care facilities are accommodating the use of vaporizers by patients on-site by putting in place specially ventilated safe inhalation rooms. However, a lack of understanding of this technology has also led some care facilities and regional governments to ban the use of vaporizers much as they have tobacco smoking.

Recently, Ontario has tabled legislation that would prohibit nearly all vaporizer use in public settings, including outdoor settings where potential risks associated with second-hand exposure are completely unproven and highly unlikely. The Canadian Medical Cannabis Council, a medical cannabis industry organization that represents a number of licensed producers (including Tilray) is encouraging a more evidence-based approach, and has submitted the following recommendation to the Ontario Government as part of their recent consultation process:

  1. The medical use of vaporizers should not be prohibited in outdoor areas.
  2. Employers should be allowed to accommodate employees who might have a medical need to vaporize cannabis within their workplace.
  3. Businesses wishing to accommodate vaporizing by authorized users should be allowed to do so as long as proper ventilation is in place.
  4. A task force made up of key stakeholders should be struck to develop policies for the medical use of vaporizers in hospitals, healthcare and long-term care facilities.
  5. Exceptions should be made on the display, sale, and demonstration of how to use vaporizers when intended for medical purposes, particularly those devices that are approved as medical devices in Canada.
We feel strongly that the shift from smoked ingestion to vaporization is a positive step for patients and for public health in Canada, and we will continue to promote a more informed discussion. If you have any questions about vaporization or medical cannabis use in general, please don’t hesitate to call Tilray’s 24/7 customer service line at 844-TILRAY1 (845-7291); our team is here ensure you have all the information you need to make the best possible choice in your course of treatment, including the potential benefits of alternatives to smoking like vaporization.